What Is Opioid-Induced Respiratory Depression?

In the 1990s, the rise in FDA-approved opioid prescriptions marked the beginning of the opioid crisis in the United States. By the mid-1990s, the initial surge of issues related to legally prescribed opioids became evident, soon followed by a second wave of fatalities linked to an expanding heroin market that drew in those already struggling with addiction. Since that time, the rates of addiction and overdose deaths associated with opioids have skyrocketed, impacting millions of Americans. The Cleveland Clinic explains that an opioid overdose occurs when these substances disrupt the brain’s ability to control breathing, leading to dangerously slow or halted respiration. This condition, known as opioid-induced respiratory depression (OIRD), poses a significant threat to life as it interferes with the body’s response to carbon dioxide levels in the blood, resulting in slow, shallow, and erratic breathing that can culminate in respiratory failure.

Respiratory depression due to opioids can lead to potentially fatal outcomes but can be reversed with the opioid receptor antagonist naloxone. However, its effectiveness can vary, and reversal may not be achievable in some situations. Timeliness is crucial when administering naloxone, as a lapse of just three to five minutes without breathing can lead to irreversible brain damage, coma, or death. OIRD is a serious risk associated with opioid misuse, overdose, or when combined with other sedatives. The addictive nature of opioids fosters tolerance and dependence, often pushing users to increase their dosages to achieve the desired effects, thereby heightening the risk of overdose. Opioid use disorder (OUD) is a multifaceted condition marked by an uncontrollable urge to use the drug, even when the person wants to stop. Fortunately, comprehensive treatment programs can help individuals regain control of their lives and achieve lasting recovery.

How Do You Diagnose Opioid-Induced Respiratory Depression?

Opioids include a variety of both prescription and illegal substances, such as Oxycodone, Fentanyl, and Heroin. All of these drugs pose a risk of addiction and can lead to hypoventilation from opioids. To diagnose opioid-induced respiratory depression, healthcare professionals typically assess a patient’s respiratory rate and oxygen saturation through pulse oximetry, along with careful observation of their breathing patterns. They may also utilize blood gas analysis to evaluate carbon dioxide levels for confirmation. The diagnostic criteria for opioid-induced respiratory depression (OIRD) include:

• Blood oxygen saturation below 90%
• Respiratory rate falling between 8 to 10 breaths per minute
• End-tidal carbon dioxide levels either below 15 or above 60 mm Hg for a minimum of 3 minutes

Despite their negative reputation, opioids play a vital role in managing severe pain, particularly in cancer patients. However, even with diligent monitoring, these patients can still face respiratory issues due to opioid use. An article from the National Library of Medicine highlights the necessity of accurately diagnosing OIRD by observing a reduction in respiratory rate and impaired gas exchange, indicated by low oxygen saturation on pulse oximetry. Respiratory depression can also stem from other conditions like pneumonia, pulmonary embolism, or multi-organ failure, in which naloxone would not be effective.

Nevertheless, the average person doesn’t need to meet all these diagnostic criteria to respond to the side effects of opioids. If someone you know is using opioids or other substances—especially since many illicit drugs are now mixed with fentanyl—and shows signs of slowed breathing, they are likely overdosing, and swift action is essential. Call emergency services immediately, administer naloxone if it’s available, and start CPR if their breathing or heart rate is undetectable.

What Is the Earliest Clinical Indicator of Respiratory Depression with a Patient on Opioids?

Opioid-induced respiratory depression can occur quite rapidly, often within minutes of administration, especially with intravenous use, where peak effects may occur around seven minutes post-injection. However, the precise timing can vary based on the specific opioid, dosage, route of administration, and individual factors like tolerance levels. Due to the potential quick onset of OIRD, it is crucial to recognize the initial signs and respond promptly. 

According to Science Direct, the first clinical sign of respiratory depression linked to opioid use is typically increased sedation or drowsiness, which usually appears before any significant drop in respiratory rate. Affected individuals may also seem lethargic, have difficulty waking, and exhibit slurred speech. It’s important to highlight that certain populations, including older adults, women, those with sleep apnea, and individuals with other respiratory issues, are at a heightened risk for experiencing respiratory depression from opioids.

Which Opioid Is Most Likely to Cause Respiratory Depression?

High-potency opioids are significantly more likely to lead to respiratory depression, particularly in individuals who take large doses of the synthetic opioid fentanyl. This powerful and highly addictive substance has played a crucial role in the alarming increase in opioid-related respiratory issues, overdoses, and fatalities. Fentanyl’s potency is estimated to be 50 to 100 times that of morphine, and even a tiny amount can trigger respiratory depression and overdose. Originally developed as a treatment for cancer patients, fentanyl has since been illicitly manufactured, with varying potencies, infiltrating all corners of the illegal drug market. Drug dealers are increasingly mixing fentanyl with other illicit substances like cocaine, heroin, and MDMA, leading many users to consume this dangerous opioid unknowingly. The presence of lethal doses of fentanyl in various drugs has exacerbated the ongoing opioid crisis.

Which Opioid Receptor Triggers Respiratory Depression?

Opioids interact with opioid receptors in the brain, resulting in sensations of pain relief, euphoria, and sedation. The mu-opioid receptor (MOR) is particularly significant as it can induce respiratory depression. When opioids activate the MOR in specific regions of the central nervous system, such as the pre-Bötzinger complex in the brainstem, they influence the regulation of breathing. This area is crucial for maintaining respiratory rhythm and also monitors carbon dioxide levels in the blood. By binding to these receptors, opioids reduce the brain’s response to elevated CO2 levels, which can lead to slower breathing and the risk of respiratory depression.

Overcome Opioid-Induced Respiratory Depression and Contact Resurgence Behavioral Health

If you or a loved one has faced opioid-induced respiratory depression, it could signal a potential opioid use disorder. The grip of opioid dependence and addiction can be so strong that even a near-fatal overdose might not deter someone from continuing to use. Surviving one overdose doesn’t guarantee safety in the future; the only sure way to prevent another is to cease usage entirely. At Resurgence Behavioral Health, our opioid addiction treatment programs offer medically supervised detox and rehabilitation to help individuals effectively overcome opioid abuse.

Treatment programs at Resurgence use a tailored approach that combines evidence-based therapies, medication management, 12-step programming, and holistic approaches that uncover and address the root causes of addiction. Our addiction specialists approach substance use disorder with compassion and nonjudgment, fostering an environment conducive to healing the body, mind, and spirit. We have built a nurturing community of peers and healthcare professionals who will support you throughout your recovery journey.

Sobriety is possible for anyone with the right kind of support. To find out more about our opioid addiction treatment programs at Resurgence Behavioral Health, reach out to us today at 855-458-0050 or chat with one of our program specialists online.

External Sources

• Cleveland Clinic – Opioid Overdose
• National Library of Medicine – Importance of the correct diagnosis of opioid-induced respiratory depression in adult cancer patients and titration of naloxone
• ScienceDirect – Respiration Depression

David Rofofsky
After growing up in New York, David chose to get help with substance abuse in California because of the state's reputation for top-tier treatment. There, he found the treatment he needed to achieve more than nine years of recovery. He's been in the drug and alcohol addiction rehab industry for eight years and now serves as the Director of Admissions for Resurgence Behavioral Health. David remains passionate about the field because he understands how hard it is to pick up the phone and ask for help. However, once the call is made, someone's life can be saved.

Research | Editorial